secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2023-04-07T23:59:59+00:00
Accession:  0001213900-23-028305
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq notifies Phoenix Biotech of MVLS non-compliance for 30 consecutive days
------------------------------------------------------------------------------

- Received Nasdaq letter on April 3, 2023; common stock MVLS below $50M minimum for 30 consecutive trading days.
- Has 180 days (until October 2, 2023) to regain compliance under Listing Rule 5810(c)(3)(C).
- To regain compliance, MVLS must close at or above $50M for at least ten consecutive business days.
- If not compliant by deadline, may transfer to Nasdaq Capital Market or face delisting with appeal rights.
- Deficiency notice has no immediate effect on listing or trading; Company monitoring options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390023028305/0001213900-23-028305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390023028305/ea176568-8k_phoenix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-028305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer